Dianthus Therapeutics | MGTA - Ingresos Por Ventas





Ventas Cambio Fecha
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
IQVIA Holdings USD 4.15B 210M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 389M 289M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Organon & Co USD 1.46B 50M 2026-03
Pharma Mar EUR 42.9M 47.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Revvity USD 711M 61.06M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.52B 180M 2026-03
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03